ACE2 and severe acute respiratory syndrome: But research has shown that the acute lung injury caused by the deletion of ACE2 after SARS-CoV infection can be alleviated by reducing the concentration of angiotensin II [14], so the increased expression of ACE2 caused by treatment with ACEI/ARBs may alleviate the lung injury of SARS-CoV-2 to some extent.